Impax Asset Management Group
WST icon

Impax Asset Management Group’s West Pharmaceutical WST Stock Holding History

Impax Asset Management Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,116
Closed -$1.35M – 327
2024
Q4 		$1.35M Buy
4,116
+1,049
+34% +$330K 0.01% 258
2024
Q3 		$921K Buy
3,067
+1,102
+56% +$337K ﹤0.01% 287
2024
Q2 		$647K Hold
1,965
– – ﹤0.01% 302
2024
Q1 		$778K Hold
1,965
– – ﹤0.01% 290
2023
Q4 		$692K Buy
1,965
+800
+69% +$283K ﹤0.01% 318
2023
Q3 		$437K Sell
1,165
-21
-2% -$8.12K ﹤0.01% 351
2023
Q2 		$454K Hold
1,186
– – ﹤0.01% 349
2023
Q1 		$411K Sell
1,186
-10,723
-90% -$3.13M ﹤0.01% 359
2022
Q4 		$2.8M Sell
11,909
-468
-4% -$111K 0.01% 212
2022
Q3 		$3.05M Buy
12,377
+1,688
+16% +$514K 0.02% 211
2022
Q2 		$3.23M Hold
10,689
– – 0.02% 210
2022
Q1 		$4.39M Sell
10,689
-55
-0.5% -$21.5K 0.02% 202
2021
Q4 		$5.04M Sell
10,744
-293
-3% -$126K 0.02% 196
2021
Q3 		$4.69M Buy
11,037
+6,600
+149% +$2.78M 0.02% 204
2021
Q2 		$1.59M Hold
4,437
– – 0.01% 259
2021
Q1 		$1.25M Buy
+4,437
New +$1.27M 0.01% 270

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Impax Asset Management Group's WST Position: Q1 2025 in Review

Impax Asset Management Group sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 4,116 shares — an estimated $1.35M sold.

Impax Asset Management Group first reported a position in WST in Q1 2021 and held it in 16 quarters. The position peaked at $5.04M in Q4 2021. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Impax Asset Management Group reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Impax Asset Management Group sold 4,116 West Pharmaceutical shares in Q1 2025, an estimated $1.35M.
  • Impax Asset Management Group first reported a position in West Pharmaceutical in Q1 2021 and held it in 16 quarters.
  • Impax Asset Management Group's West Pharmaceutical position peaked at $5.04M in Q4 2021.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Impax Asset Management Group's 13F filing for Q1 2025, filed 29 Apr 2025.